Tadataka (Tachi) Yamada likes to hire employees who have moved around the world, but he's no stranger to change himself. Since beginning his career as a physician–scientist, he has headed up research and development at GlaxoSmithKline and has directed The Bill & Melinda Gates Foundation's Global Health Program. In 2012, he returned to industry to take up a position as Takeda's Chief Medical and Scientific Officer. He's bringing change with him, both to Takeda and to the Japanese pharmaceutical industry, he tells Asher Mullard.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Tachi Yamada. Nat Rev Drug Discov 12, 658–659 (2013). https://doi.org/10.1038/nrd4110
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4110
